[1]李晓君.麦角新碱联合米索前列醇、缩宫素在胎盘早剥产后大出血的临床效果及对应激反应的影响[J].医学信息,2023,36(19):141-143,147.[doi:10.3969/j.issn.1006-1959.2023.19.031]
 LI Xiao-jun.Clinical Effect of Ergometrine Combined with Misoprostol and Oxytocin in Postpartum Hemorrhage of Placental Abruption and its Effect on Stress Response[J].Journal of Medical Information,2023,36(19):141-143,147.[doi:10.3969/j.issn.1006-1959.2023.19.031]
点击复制

麦角新碱联合米索前列醇、缩宫素在胎盘早剥产后大出血的临床效果及对应激反应的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年19期
页码:
141-143,147
栏目:
药物与临床
出版日期:
2023-10-01

文章信息/Info

Title:
Clinical Effect of Ergometrine Combined with Misoprostol and Oxytocin in Postpartum Hemorrhage of Placental Abruption and its Effect on Stress Response
文章编号:
1006-1959(2023)19-0141-04
作者:
李晓君
(永丰县人民医院妇产科,江西 永丰 331500)
Author(s):
LI Xiao-jun
(Department of Obstetrics and Gynecology,Yongfeng County People’s Hospital,Yongfeng 331500,Jiangxi,China)
关键词:
麦角新碱米索前列醇缩宫素胎盘早剥产后大出血应激反应
Keywords:
ErgometrineMisoprostolOxytocinPlacental abruptionPostpartum hemorrhageStress reaction
分类号:
R714.46+1
DOI:
10.3969/j.issn.1006-1959.2023.19.031
文献标志码:
A
摘要:
目的 观察麦角新碱联合米索前列醇、缩宫素在胎盘早剥产后大出血中的临床效果及对应激反应的影响。方法 选取2019年1月-2022年3月我院诊治的60例胎盘早剥产后大出血产妇为研究对象,采用随机数字表法分为对照组(n=30)和观察组(n=30)。对照组采用缩宫素+米索前列醇治疗,观察组在对照组基础上联合麦角新碱治疗,比较两组临床效果、止血指标(出血量、出血持续时间、血红蛋白水平)、应激反应指标(收缩压、舒张压、心率)、不良反应发生率、母婴不良事件发生率。结果 观察组治疗总有效率为93.33%,高于对照组的80.00%(P<0.05);观察组出血量、出血持续时间均小于对照组,血红蛋白水平高于对照组(P<0.05);两组治疗后收缩压、舒张压、心率均高于治疗前(P<0.05),但观察组与对照组比较,差异无统计学意义(P>0.05);观察组不良反应发生率与对照组比较,差异无统计学意义(P>0.05);观察组母婴不良事件发生率低于对照组(P<0.05)。结论 麦角新碱联合米索前列醇、缩宫素在胎盘早剥产后大出血中的临床效果确切,可提升止血效果,降低母婴不良事件发生率,且对血压和心率影响较小,安全性较高。
Abstract:
Objective To observe the clinical effect of ergometrine combined with misoprostol and oxytocin in postpartum hemorrhage of placental abruption and its effect on stress response.Methods From January 2019 to March 2022, 60 parturients with postpartum hemorrhage of placental abruption diagnosed and treated in our hospital were selected as the research objects. They were divided into control group (n=30) and observation group (n=30) by random number table method. The control group was treated with oxytocin+misoprostol, and the observation group was treated with ergometrine on the basis of the control group. The clinical effect, hemostatic index (bleeding volume, bleeding duration, hemoglobin level), stress response index (systolic blood pressure, diastolic blood pressure, heart rate), incidence of adverse reactions, incidence of maternal and infant adverse events were compared between the two groups.Results The total effective rate of treatment in the observation group was 93.33%, which was higher than 80.00% in the control group (P<0.05). The amount of bleeding and the duration of bleeding in the observation group were less than those in the control group, and the hemoglobin level was higher than that in the control group (P<0.05). The systolic blood pressure, diastolic blood pressure and heart rate of the two groups after treatment were higher than those before treatment (P<0.05), but there was no significant difference between the observation group and the control group (P>0.05). There was no significant difference in the incidence of adverse reactions between the observation group and the control group (P>0.05). The incidence of maternal and infant adverse events in the observation group was lower than that in the control group (P<0.05).Conclusion Ergometrine combined with misoprostol and oxytocin has a definite clinical effect in postpartum hemorrhage of placental abruption, which can improve the hemostatic effect and reduce the incidence of maternal and infant adverse events. Meanwhile, it has little effect on blood pressure and heart rate, and has high safety in clinical treatment.

参考文献/References:

[1]Inoue A,Kondoh E,Suginami K,et al.Vaginal delivery after placental abruption with intrauterine fetal death: A 20-year single-center experience[J].J Obstet Gynaecol Res,2017,43(4):676-681.[2]周新娥,梅又文,程薇,等.胎盘早剥并发产后出血的危险因素及围产结局分析[J].中国计划生育和妇产科,2017,9(12):13-17.[3]杨妍.宫体注射卡前列素氨丁三醇对预防剖宫产产后出血的效果观察[J].中国妇幼保健,2017,32(4):700-702.[4]刘瑞枝.卡前列素氨丁三醇联合米索前列醇在产后出血中的应用效果[J].山西医药杂志,2016,45(20):2420-2422.[5]谷琳,杨帆,刘庆研,等.缩宫素、米索和卡前列素氨丁三醇治疗胎盘早剥产后大出血的临床研究[J].临床与病理杂志,2021,41(9):2066-2071.[6]李微,王秀梅,邢梅.垂体后叶素联合卡前列素氨丁三醇治疗胎盘早剥产后大出血的临床疗效分析[J].河北医学,2016,22(2):221-223.[7]周凯苏,赵卫华,柯玮琳,等.卡前列素氨丁三醇联合垂体后叶素治疗宫缩乏力性产后出血疗效研究[J].检验医学与临床,2016,13(20):2872-2873.[8]李剑.垂体后叶素联合卡前列素氨丁三醇治疗胎盘早剥产后大出血的临床应用分析[J].中国医药科学,2020,10(2):44-46.[9]于万芹.卡前列素氨丁三醇联合缩宫素在减少凶险性前置胎盘产后出血中的临床效果[J].河北医药,2017,39(12):1877-1879,1883.[10]冯苗苗,邢梅.卡前列素氨丁三醇联合卡贝缩宫素对前置胎盘剖宫产产后出血的疗效观察[J].中国计划生育和妇产科,2017,9(9):56-58.[11]周新枚,华秀兰,何昱雯.卡前列素氨丁三醇联合卡孕栓防治宫缩乏力性产后出血疗效观察[J].海南医学,2016,27(15):2535-2536.[12]胡静.卡前列素氨丁三醇联合缩宫素治疗子宫收缩乏力性出血的临床研究[J].现代药物与临床,2017,32(11):2177-2181.[13]Fadl SA,Linnau KF,Dighe MK.Placental abruption and hemorrhage-review of imaging appearance[J].Emerg Radiol,2019,26(1):87-97.[14]潘琴.卡前列素氨丁三醇联合缩宫素在高危妊娠且行剖宫产术中的应用价值分析[J].解放军医药杂志,2017,29(9):6-8,16.[15]李玉梅,谭白菊.益母草注射液联合卡前列素氨丁三醇用于预防剖宫产产后出血的临床观察[J].中国药房,2017,28(9):1197-1200.[16]党玮,李冰,付天芳,等.卡前列素氨丁三醇、米索前列醇和缩宫素联合应用治疗产后出血的疗效分析[J].药物评价研究,2016,39(3):433-436.[17]赵雅菲.垂体后叶素、缩宫素与卡前列素氨丁三醇联合治疗胎盘早剥产后出血的效果及安全性[J].白求恩医学杂志,2020,18(4):340-342.[18]宋小侠,卢燕玲,翁廷松,等.马来酸麦角新碱、卡贝缩宫素及卡前列素氨丁三醇预防和治疗宫缩乏力性产后出血效果的比较[J].广东医学,2017,38(18):2850-2852,2855.

相似文献/References:

[1]周 鑫,王 明,魏 宏.药物流产终止乙肝病毒感染患者10~14周妊娠的 安全性及有效性分析[J].医学信息,2018,31(12):112.[doi:10.3969/j.issn.1006-1959.2018.12.035]
 ZHOU Xin,WANG Ming,WEI Hong.Analysis of Safety and Effectiveness of Stopping Hepatitis B Virus Infection in 10 to 14 Weeks of Pregnancy by Drug Abortion[J].Journal of Medical Information,2018,31(19):112.[doi:10.3969/j.issn.1006-1959.2018.12.035]
[2]陈晓娟,卢芳芳,周芳英.丙泊酚、枸橼酸舒芬太尼联合米索前列醇用于无痛人流术的效果[J].医学信息,2019,32(23):154.[doi:10.3969/j.issn.1006-1959.2019.23.048]
 CHEN Xiao-juan,LU Fang-fang,ZHOU Fang-ying.Effect of Propofol,Sufentanil citrate and Misoprostol on Painless Abortion[J].Journal of Medical Information,2019,32(19):154.[doi:10.3969/j.issn.1006-1959.2019.23.048]
[3]张 勇.阴道放置米索前列醇在终止6~10周妊娠负压吸宫术前的应用[J].医学信息,2019,32(24):143.[doi:10.3969/j.issn.1006-1959.2019.24.051]
 ZHANG Yong.Application of Vaginal Misoprostol Before Termination of Negative Pressure Uterine Aspiration with 6 to 10 Weeks[J].Journal of Medical Information,2019,32(19):143.[doi:10.3969/j.issn.1006-1959.2019.24.051]
[4]王 敏.宫颈扩张球囊与米索前列醇在足月妊娠初产妇促宫颈成熟引产中的效果比较[J].医学信息,2021,34(22):94.[doi:10.3969/j.issn.1006-1959.2021.22.028]
 WANG Min.Comparison of Cervical Dilation Balloon and Misoprostol in Promoting Cervical Ripening and Induction of Labor in Primiparae with Full-term Pregnancy[J].Journal of Medical Information,2021,34(19):94.[doi:10.3969/j.issn.1006-1959.2021.22.028]
[5]张志巧.宫颈扩张球囊与米索前列醇在足月妊娠初产妇促宫颈成熟引产中的临床疗效及安全性[J].医学信息,2021,34(24):99.[doi:10.3969/j.issn.1006-1959.2021.24.023]
 ZHANG Zhi-qiao.Clinical Efficacy and Safety of Cervical Dilation Balloon and Misoprostol in Promoting Cervical Ripening and Induction of Labor in Primiparae with Full-term Pregnancy[J].Journal of Medical Information,2021,34(19):99.[doi:10.3969/j.issn.1006-1959.2021.24.023]
[6]许淑萍.米索前列醇对宫内节育器取出术绝经期女性软化宫颈的效果[J].医学信息,2021,34(24):144.[doi:10.3969/j.issn.1006-1959.2021.24.037]
 XU Shu-ping.Effect of Misoprostol on Cervical Softening in Intrauterine Device Removal Surgery in Postmenopausal Women[J].Journal of Medical Information,2021,34(19):144.[doi:10.3969/j.issn.1006-1959.2021.24.037]
[7]王金英.卡前列甲酯栓联合麦角新碱预防瘢痕子宫剖宫产产后出血的临床效果及安全性[J].医学信息,2023,36(23):107.[doi:10.3969/j.issn.1006-1959.2023.23.027]
 WANG Jin-ying.Clinical Effect and Safety of Methyl Carprost Suppositories Combined with Ergonovine in Preventing Postpartum Hemorrhage of Cesarean Section of Scar Uterus[J].Journal of Medical Information,2023,36(19):107.[doi:10.3969/j.issn.1006-1959.2023.23.027]

更新日期/Last Update: 1900-01-01